{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T21:56:08Z","timestamp":1784584568357,"version":"3.55.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82374067"],"award-info":[{"award-number":["No.82374067"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82274125"],"award-info":[{"award-number":["No.82274125"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-025-01673-z","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:03:15Z","timestamp":1760605395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Spatial metabolomics reveals the effects of Acanthopanax senticosus on region-specific alterations in neurotransmitters and metabolites levels in the brains of \u03b1-syn transgenic Parkinson\u2019s disease model mice"],"prefix":"10.1007","volume":"40","author":[{"given":"Qi","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangyou","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4812-3494","authenticated-orcid":false,"given":"Shumin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"1673_CR1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrneurol.2017.27","volume":"13","author":"D Aarsland","year":"2017","unstructured":"Aarsland D, Creese B, Politis M, Chaudhuri KR, Ffytche DH, Weintraub D, Ballard C (2017) Cognitive decline in Parkinson disease. Nat Rev Neurol 13:217\u2013231","journal-title":"Nat Rev Neurol"},{"key":"1673_CR2","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101840","volume":"85","author":"MH Ahmad","year":"2023","unstructured":"Ahmad MH, Rizvi MA, Ali M, Mondal AC (2023) Neurobiology of depression in Parkinson\u2019s disease: insights into epidemiology, molecular mechanisms and treatment strategies. Ageing Res Rev 85:101840","journal-title":"Ageing Res Rev"},{"key":"1673_CR3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/cne.903510204","volume":"351","author":"T Arendt","year":"1995","unstructured":"Arendt T, Br\u00fcckner MK, Bigl V, Marcova L (1995) Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer\u2019s disease. III. The basal forebrain compared with other subcortical areas. J Comp Neurol 351:223\u2013246","journal-title":"J Comp Neurol"},{"key":"1673_CR4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.14108","volume":"27","author":"R Balestrino","year":"2020","unstructured":"Balestrino R, Schapira AHV (2020) Parkinson disease. Eur J Neurol 27:27\u201342","journal-title":"Eur J Neurol"},{"key":"1673_CR5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/jnnp.69.3.319","volume":"69","author":"T Benke","year":"2000","unstructured":"Benke T, Hohenstein C, Poewe W, Butterworth B (2000) Repetitive speech phenomena in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 69:319\u2013324","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1673_CR6","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1111\/ejn.14886","volume":"52","author":"IL Boccalaro","year":"2020","unstructured":"Boccalaro IL, Schwerdel C, Cristi\u00e1-Lara L, Fritschy JM, Rubi L (2020) Dopamine depletion induces neuron-specific alterations of GABAergic transmission in the mouse striatum. Eur J Neurosci 52:3353\u20133374","journal-title":"Eur J Neurosci"},{"key":"1673_CR7","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s10517-010-1023-z","volume":"149","author":"EV Bocharov","year":"2010","unstructured":"Bocharov EV, Ivanova-Smolenskaya IA, Poleshchuk VV, Kucheryanu VG, Il\u2019enko VA, Bocharova OA (2010) Therapeutic efficacy of the neuroprotective plant adaptogen in neurodegenerative disease (Parkinson\u2019s disease as an example). Bull Exp Biol Med 149:682\u2013684","journal-title":"Bull Exp Biol Med"},{"key":"1673_CR8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00702-008-0132-6","volume":"116","author":"JL Bosboom","year":"2009","unstructured":"Bosboom JL, Stoffers D, Wolters E, Stam CJ, Berendse HW (2009) MEG resting state functional connectivity in parkinson\u2019s disease related dementia. J Neural Transm (Vienna) 116:193\u2013202","journal-title":"J Neural Transm (Vienna)"},{"key":"1673_CR9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1021\/acs.analchem.7b04733","volume":"90","author":"AR Buchberger","year":"2018","unstructured":"Buchberger AR, Delaney K, Johnson J, Li L (2018) Mass spectrometry imaging: a review of emerging advancements and future insights. Anal Chem 90:240\u2013265","journal-title":"Anal Chem"},{"key":"1673_CR10","doi-asserted-by":"crossref","first-page":"e162138","DOI":"10.1172\/jci.insight.162138","volume":"7","author":"A Buck","year":"2022","unstructured":"Buck A, Prade VM, Kunzke T, Erben RG, Walch A (2022) Spatial metabolomics reveals upregulation of several pyrophosphate-producing pathways in cortical bone of hyp mice. JCI Insight 7:e162138","journal-title":"JCI Insight"},{"key":"1673_CR11","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/acn3.246","volume":"2","author":"C Buddhala","year":"2015","unstructured":"Buddhala C, Loftin SK, Kuley BM, Cairns NJ, Campbell MC, Perlmutter JS, Kotzbauer PT (2015) Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease. Ann Clin Transl Neurol 2:949\u2013959","journal-title":"Ann Clin Transl Neurol"},{"key":"1673_CR12","doi-asserted-by":"crossref","first-page":"a024091","DOI":"10.1101\/cshperspect.a024091","volume":"8","author":"J Burr\u00e9","year":"2018","unstructured":"Burr\u00e9 J, Sharma M, S\u00fcdhof TC (2018) Cell biology and pathophysiology of \u03b1-synuclein. Cold Spring Harb Perspect Med 8:a024091","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1673_CR13","first-page":"2308","volume":"122","author":"H Chen","year":"2009","unstructured":"Chen H, Zhuang P, Zhang YQ, Li JY, Li YJ (2009) Neuronal firing in the globus pallidus internus and the ventrolateral thalamus related to parkinsonian motor symptoms. Chin Med J Engl 122:2308\u20132314","journal-title":"Chin Med J Engl"},{"key":"1673_CR14","first-page":"1883","volume":"25","author":"X Cheng","year":"2010","unstructured":"Cheng X, Xia L (2010) Acanthopanax senticosus combined with Madopar in the treatment of Parkinson \u2018s disease. Guangming J Chin Med 25:1883\u20131884","journal-title":"Guangming J Chin Med"},{"key":"1673_CR15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0022-510X(93)90316-Q","volume":"116","author":"LG Chia","year":"1993","unstructured":"Chia LG, Cheng FC, Kuo JS (1993) Monoamines and their metabolites in plasma and lumbar cerebrospinal fluid of Chinese patients with parkinson\u2019s disease. J Neurol Sci 116:125\u2013134","journal-title":"J Neurol Sci"},{"key":"1673_CR16","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/WNR.0000000000001322","volume":"30","author":"A Choudhury","year":"2019","unstructured":"Choudhury A, Solanki B, Singh S, Sahu U, Parvez S, Kar S, Ganguly S (2019) Persistent peripheral presence of Staphylococcus aureus promotes histone H3 hypoacetylation and decreases tyrosine hydroxylase protein level in rat brain tissues. Neuroreport 30:1087\u20131094","journal-title":"Neuroreport"},{"key":"1673_CR17","unstructured":"Committee SP (2020) pharmacopoeia of the people\u2019s republic of china. China Pharmaceutical Science and Technology"},{"key":"1673_CR18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00005768-199701000-00008","volume":"29","author":"JM Davis","year":"1997","unstructured":"Davis JM, Bailey SP (1997) Possible mechanisms of central nervous system fatigue during exercise. Med Sci Sports Exerc 29:45\u201357","journal-title":"Med Sci Sports Exerc"},{"issue":"03","key":"1673_CR19","first-page":"187","volume":"30","author":"W Dong","year":"2024","unstructured":"Dong W, Hao W, Yang W, Huang P (2024) Exploration of role of yin and yang syndrome differentiation in parkinson\u2019s disease. Chin J Experimental Traditional Med Formulae 30(03):187\u2013195","journal-title":"Chin J Experimental Traditional Med Formulae"},{"key":"1673_CR20","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/BF01485901","volume":"38","author":"H Ehringer","year":"1960","unstructured":"Ehringer H, Hornykiewicz O (1960) [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system]. Klin Wochenschr 38:1236\u20131239","journal-title":"Klin Wochenschr"},{"key":"1673_CR21","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/mds.26048","volume":"29","author":"AJ Espay","year":"2014","unstructured":"Espay AJ, Lewitt PA, Kaufmann H (2014) Norepinephrine deficiency in parkinson\u2019s disease: the case for noradrenergic enhancement. Mov Disord 29:1710\u20131719","journal-title":"Mov Disord"},{"key":"1673_CR22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00702-018-1952-7","volume":"126","author":"JPM Finberg","year":"2019","unstructured":"Finberg JPM (2019) Inhibitors of MAO-B and COMT: their effects on brain dopamine levels and uses in parkinson\u2019s disease. J Neural Transm (Vienna) 126:433\u2013448","journal-title":"J Neural Transm (Vienna)"},{"key":"1673_CR23","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/dna.2016.3569","volume":"36","author":"J Florczak-Wyspianska","year":"2017","unstructured":"Florczak-Wyspianska J, Rozycka A, Wolny L, Lianeri M, Kozubski W, Dorszewska J (2017) Polymorphisms of COMT (c.649G\u2009>\u2009A), MAO-A (c.1460C\u2009>\u2009T), NET (c.1287G\u2009>\u2009A) genes and the level of catecholamines, serotonin in patients with Parkinson\u2019s disease. DNA Cell Biol 36:501\u2013512","journal-title":"DNA Cell Biol"},{"key":"1673_CR24","first-page":"159","volume":"36","author":"X Gao","year":"2020","unstructured":"Gao X, Liu JJ, Wu J, Chen PP, Liu SM (2020) Effect of Baichanting compound on dopamine and pathological changes in brain Og Transgenic mice with parkinson\u2019s disease. Pharmacol Clin Chin Mater Med 36:159\u2013162","journal-title":"Pharmacol Clin Chin Mater Med"},{"key":"1673_CR25","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.parkreldis.2008.01.010","volume":"14","author":"DS Goldstein","year":"2008","unstructured":"Goldstein DS, Holmes C, Bentho O, Sato T, Moak J, Sharabi Y, Imrich R, Conant S, Eldadah BA (2008) Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy. Parkinsonism Relat Disord 14:600\u2013607","journal-title":"Parkinsonism Relat Disord"},{"key":"1673_CR26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.parkreldis.2016.07.009","volume":"31","author":"DS Goldstein","year":"2016","unstructured":"Goldstein DS, Holmes C, Sullivan P, Jinsmaa Y, Kopin IJ, Sharabi Y (2016) Elevated cerebrospinal fluid ratios of cysteinyl-dopamine\/3,4-dihydroxyphenylacetic acid in parkinsonian synucleinopathies. Parkinsonism Relat Disord 31:79\u201386","journal-title":"Parkinsonism Relat Disord"},{"key":"1673_CR27","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0140-6736(14)60683-8","volume":"384","author":"R Gray","year":"2014","unstructured":"Gray R, Ives N, Rick C, Patel S, Gray A, Jenkinson C, Mcintosh E, Wheatley K, Williams A, Clarke CE (2014) Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for parkinson\u2019s disease (PD MED): a large, open-label, pragmatic randomised trial. Lancet 384:1196\u20131205","journal-title":"Lancet"},{"key":"1673_CR28","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1007\/s00415-013-7126-5","volume":"260","author":"MK Herbert","year":"2013","unstructured":"Herbert MK, Kuiperij H, Bloem BR, Verbeek MM (2013) Levels of HVA, 5-HIAA, and MHPG in the CSF of vascular parkinsonism compared to parkinson\u2019s disease and controls. J Neurol 260:3129\u20133133","journal-title":"J Neurol"},{"key":"1673_CR29","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s00381-002-0604-1","volume":"18","author":"MT Herrero","year":"2002","unstructured":"Herrero MT, Barcia C, Navarro JM (2002) Functional anatomy of thalamus and basal ganglia. Childs Nerv Syst 18:386\u2013404","journal-title":"Childs Nerv Syst"},{"key":"1673_CR30","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2217\/nmt-2020-0043","volume":"10","author":"P Huot","year":"2020","unstructured":"Huot P (2020) Monoamine oxidase A inhibition and Parkinson\u2019s disease. Neurodegener Dis Manag 10:335\u2013337","journal-title":"Neurodegener Dis Manag"},{"key":"1673_CR31","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00221-013-3621-2","volume":"230","author":"P Huot","year":"2013","unstructured":"Huot P, Fox SH (2013) The serotonergic system in motor and non-motor manifestations of parkinson\u2019s disease. Exp Brain Res 230:463\u2013476","journal-title":"Exp Brain Res"},{"key":"1673_CR32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/1570159X16666180302115032","volume":"17","author":"S Jamwal","year":"2019","unstructured":"Jamwal S, Kumar P (2019) Insight into the emerging role of striatal neurotransmitters in the pathophysiology of parkinson\u2019s disease and huntington\u2019s disease: a review. Curr Neuropharmacol 17:165\u2013175","journal-title":"Curr Neuropharmacol"},{"key":"1673_CR33","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.pharep.2017.05.016","volume":"69","author":"K Kami\u0144ska","year":"2017","unstructured":"Kami\u0144ska K, Lenda T, Konieczny J, Czarnecka A, Lorenc-Koci E (2017) Depressive-like neurochemical and behavioral markers of parkinson\u2019s disease after 6-OHDA administered unilaterally to the rat medial forebrain bundle. Pharmacol Rep 69:985\u2013994","journal-title":"Pharmacol Rep"},{"key":"1673_CR34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000341998","volume":"11","author":"AA Kehagia","year":"2013","unstructured":"Kehagia AA, Barker RA, Robbins TW (2013) Cognitive impairment in Parkinson\u2019s disease: the dual syndrome hypothesis. Neurodegener Dis 11:79\u201392","journal-title":"Neurodegener Dis"},{"key":"1673_CR35","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/0306-4522(82)90054-9","volume":"7","author":"C K\u00f6hler","year":"1982","unstructured":"K\u00f6hler C, Steinbusch H (1982) Identification of serotonin and non-serotonin-containing neurons of the mid-brain Raphe projecting to the entorhinal area and the hippocampal formation. A combined immunohistochemical and fluorescent retrograde tracing study in the rat brain. Neuroscience 7:951\u2013975","journal-title":"Neuroscience"},{"key":"1673_CR36","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.neuron.2008.11.005","volume":"60","author":"AC Kreitzer","year":"2008","unstructured":"Kreitzer AC, Malenka RC (2008) Striatal plasticity and basal ganglia circuit function. Neuron 60:543\u2013554","journal-title":"Neuron"},{"key":"1673_CR37","first-page":"14","volume":"01","author":"S Kuang","year":"2004","unstructured":"Kuang S, Xie M, Yang D, Zhang J, Peng H (2004) Clinical study on treating Parkinson \u2018s disease by Acanthopanax senticosus. Jilin J Chin Med 01:14\u201315","journal-title":"Jilin J Chin Med"},{"key":"1673_CR38","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/10408363.2021.1942781","volume":"58","author":"PY Lee","year":"2021","unstructured":"Lee PY, Yeoh Y, Omar N, Pung YF, Lim LC, Low TY (2021) Molecular tissue profiling by MALDI imaging: recent progress and applications in cancer research. Crit Rev Clin Lab Sci 58:513\u2013529","journal-title":"Crit Rev Clin Lab Sci"},{"key":"1673_CR39","first-page":"2111","volume":"42","author":"PA Lewitt","year":"1992","unstructured":"Lewitt PA, Galloway MP, Matson W, Milbury P, Mcdermott M, Srivastava DK, Oakes D (1992) Markers of dopamine metabolism in Parkinson\u2019s disease. Parkinson Study Group Neurology 42:2111\u20132117","journal-title":"Parkinson Study Group Neurology"},{"key":"1673_CR40","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.brainres.2011.06.057","volume":"1408","author":"P Lewitt","year":"2011","unstructured":"Lewitt P, Schultz L, Auinger P, Lu M (2011) CSF xanthine, homovanillic acid, and their ratio as biomarkers of parkinson\u2019s disease. Brain Res 1408:88\u201397","journal-title":"Brain Res"},{"key":"1673_CR41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neuint.2014.04.012","volume":"72","author":"XZ Li","year":"2014","unstructured":"Li XZ, Zhang SN, Wang KX, Liu SM, Lu F (2014) iTRAQ-based quantitative proteomics study on the neuroprotective effects of extract of acanthopanax senticosus Harm on SH-SY5Y cells overexpressing A53T mutant \u03b1-synuclein. Neurochem Int 72:37\u201347","journal-title":"Neurochem Int"},{"key":"1673_CR42","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ptr.5522","volume":"30","author":"XZ Li","year":"2016","unstructured":"Li XZ, Zhang SN, Lu F, Liu SM (2016) Microarray expression analysis for the paradoxical roles of acanthopanax senticosus Harms in treating \u03b1-synucleinopathies. Phytother Res 30:243\u2013252","journal-title":"Phytother Res"},{"key":"1673_CR43","volume":"9","author":"TH Lian","year":"2018","unstructured":"Lian TH, Guo P, Zuo LJ, Hu Y, Yu SY, Liu L, Jin Z, Yu QJ, Wang RD, Li LX, Piao YS, Zhang W (2018) An investigation on the clinical features and neurochemical changes in parkinson\u2019s disease with depression. Front Psychiatry 9:723","journal-title":"Front Psychiatry"},{"key":"1673_CR44","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.phymed.2012.02.006","volume":"19","author":"SM Liu","year":"2012","unstructured":"Liu SM, Li XZ, Huo Y, Lu F (2012) Protective effect of extract of Acanthopanax senticosus Harms on dopaminergic neurons in Parkinson\u2019s disease mice. Phytomedicine 19:631\u2013638","journal-title":"Phytomedicine"},{"key":"1673_CR45","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s11655-018-2935-5","volume":"24","author":"SM Liu","year":"2018","unstructured":"Liu SM, Li XZ, Zhang SN, Yang ZM, Wang KX, Lu F, Wang CZ, Yuan CS (2018) Acanthopanax senticosus protects structure and function of mesencephalic mitochondria in a mouse model of parkinson\u2019s disease. Chin J Integr Med 24:835\u2013843","journal-title":"Chin J Integr Med"},{"key":"1673_CR46","doi-asserted-by":"crossref","unstructured":"Lu Y, Gao X, Nan Y, Mohammed SaD, Fu J, Wang T, Wang C, Yuan C, Lu F, Liu S (2023) Acanthopanax senticosus Harms improves Parkinson\u2019s disease by regulating gut microbial structure and metabolic disorders. Heliyon 9:e18045","DOI":"10.1016\/j.heliyon.2023.e18045"},{"key":"1673_CR47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00726-012-1382-z","volume":"46","author":"J Menzie","year":"2014","unstructured":"Menzie J, Pan C, Prentice H, Wu JY (2014) Taurine and central nervous system disorders. Amino Acids 46:31\u201346","journal-title":"Amino Acids"},{"issue":"8","key":"1673_CR48","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.3390\/ijms23084453","volume":"23","author":"MH Nam","year":"2022","unstructured":"Nam MH, Sa M, Ju YH, Park MG, Lee CJ (2022) Revisiting the Role of Astrocytic MAOB in Parkinson\u2019s Disease. Int J Mol Sci 23(8):4453","journal-title":"Int J Mol Sci"},{"key":"1673_CR49","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1021\/cr078224o","volume":"108","author":"DE Nichols","year":"2008","unstructured":"Nichols DE, Nichols CD (2008) Serotonin receptors. Chem Rev 108:1614\u20131641","journal-title":"Chem Rev"},{"key":"1673_CR50","volume":"9","author":"RL O\u2019gorman Tuura","year":"2018","unstructured":"O\u2019gorman Tuura RL, Baumann CR, Baumann-Vogel H (2018) Beyond dopamine: GABA, glutamate, and the axial symptoms of Parkinson disease. Front Neurol 9:806","journal-title":"Front Neurol"},{"key":"1673_CR51","first-page":"94","volume":"36","author":"YD Ren","year":"2016","unstructured":"Ren YD, Jing YE, Zhang SX, Wang H-Y, Lu F, Liu SM (2016) Effect of baichanting compound on dopamine contents in parkinson\u2019s disease model mice. Zhongguo Zhong Xi Yi Jie He Za Zhi 36:94\u201398","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"1673_CR52","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","volume":"363","author":"A Samii","year":"2004","unstructured":"Samii A, Nutt JG, Ransom BR (2004) Parkinson\u2019s disease. Lancet 363:1783\u20131793","journal-title":"Lancet"},{"key":"1673_CR53","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0006-8993(83)90993-9","volume":"275","author":"B Scatton","year":"1983","unstructured":"Scatton B, Javoy-Agid F, Rouquier L, Dubois B, Agid Y (1983) Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in parkinson\u2019s disease. Brain Res 275:321\u2013328","journal-title":"Brain Res"},{"key":"1673_CR54","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s41592-019-0551-3","volume":"16","author":"M Shariatgorji","year":"2019","unstructured":"Shariatgorji M, Nilsson A, Fridjonsdottir E, Vallianatou T, K\u00e4llback P, Katan L, S\u00e4vmarker J, Mantas I, Zhang X, Bezard E, Svenningsson P, Odell LR, Andr\u00e9n PE (2019) Comprehensive mapping of neurotransmitter networks by MALDI-MS imaging. Nat Methods 16:1021\u20131028","journal-title":"Nat Methods"},{"key":"1673_CR55","first-page":"2538","volume":"31","author":"Z Shuai-Nan","year":"2016","unstructured":"Shuai-Nan Z, Xu-Zhao L, Fang L, Shu-Min L (2016) Proteomics study on SH-SY5Y cells overexpressing wild-type \u03b1-synuclein treated with acanthopanax senticosus harms. China J Traditional Chin Med Pharm 31:2538\u20132542","journal-title":"China J Traditional Chin Med Pharm"},{"key":"1673_CR56","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1023\/A:1015093619476","volume":"32","author":"IG Sil\u2019kis","year":"2002","unstructured":"Sil\u2019kis IG (2002) A possible mechanism for the dopamine-evoked synergistic disinhibition of thalamic neurons via the direct and indirect pathways in the basal ganglia. Neurosci Behav Physiol 32:205\u2013212","journal-title":"Neurosci Behav Physiol"},{"key":"1673_CR57","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1073\/pnas.1808950116","volume":"116","author":"C Sun","year":"2019","unstructured":"Sun C, Li T, Song X, Huang L, Zang Q, Xu J, Bi N, Jiao G, Hao Y, Chen Y, Zhang R, Luo Z, Li X, Wang L, Wang Z, Song Y, He J, Abliz Z (2019) Spatially resolved metabolomics to discover tumor-associated metabolic alterations. Proc Natl Acad Sci U S A 116:52\u201357","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1673_CR58","first-page":"103","volume":"9","author":"C V\u00e1radi","year":"2020","unstructured":"V\u00e1radi C (2020) Clinical features of parkinson\u2019s disease: the evolution of critical symptoms. Biology (Basel) 9:103","journal-title":"Biology (Basel)"},{"key":"1673_CR59","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neuro.2021.01.002","volume":"83","author":"K Wang","year":"2021","unstructured":"Wang K, Shi Y, Liu W, Liu S, Sun MZ (2021) Taurine improves neuron injuries and cognitive impairment in a mouse Parkinson\u2019s disease model through inhibition of microglial activation. Neurotoxicology 83:129\u2013136","journal-title":"Neurotoxicology"},{"key":"1673_CR60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00726-021-03104-6","volume":"54","author":"K Wang","year":"2022","unstructured":"Wang K, Zhang B, Tian T, Zhang B, Shi G, Zhang C, Li G, Huang M (2022) Taurine protects dopaminergic neurons in paraquat-induced parkinson\u2019s disease mouse model through PI3K\/Akt signaling pathways. Amino Acids 54:1\u201311","journal-title":"Amino Acids"},{"key":"1673_CR61","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0197-0186(85)90108-1","volume":"7","author":"BH Westerink","year":"1985","unstructured":"Westerink BH (1985) Sequence and significance of dopamine metabolism in the rat brain. Neurochem Int 7:221\u2013227","journal-title":"Neurochem Int"},{"key":"1673_CR62","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3390\/pr10020388","volume":"10","author":"J Wu","year":"2022","unstructured":"Wu J, Rong Z, Xiao P, Li Y (2022) Imaging method by matrix-assisted laser desorption\/ionization mass spectrometry (MALDI-MS) for tissue or tumor: a mini review. Processes 10:388","journal-title":"Processes"},{"key":"1673_CR63","first-page":"177","volume":"54","author":"L Xue-Mei","year":"2023","unstructured":"Xue-Mei L, Yuan G, Jian L, Xiao-Ying L, Li Z (2023) Advances in the role of 5-HT neurotransmitter system in psychiatric symptoms and cognitive impairment associated with parkinson\u2019s disease. Prog Physiol Sci 54:177\u2013184","journal-title":"Prog Physiol Sci"},{"key":"1673_CR64","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2019.109818","volume":"98","author":"M Yeom","year":"2020","unstructured":"Yeom M, Ahn S, Oh JY, Kim SY, Lee H, Hahm DH, Park HJ (2020) Atopic dermatitis induces anxiety- and depressive-like behaviors with concomitant neuronal adaptations in brain reward circuits in mice. Prog Neuropsychopharmacol Biol Psychiatry 98:109818","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1673_CR65","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jep.2015.01.046","volume":"163","author":"SN Zhang","year":"2015","unstructured":"Zhang SN, Li XZ, Lu F, Liu SM (2015) Cerebral potential biomarkers discovery and metabolic pathways analysis of \u03b1-synucleinopathies and the dual effects of acanthopanax senticosus harms on central nervous system through metabolomics analysis. J Ethnopharmacol 163:264\u2013272","journal-title":"J Ethnopharmacol"},{"key":"1673_CR66","unstructured":"Zheng Q, Yu D, Geng X, Lu F, Liu S (2024) Research progress of Acanthopanax senticosus and its compound in prevention and treatment of parkinson\u2019s disease. J Liaoning Univ Traditional Chin Med, pp 1\u201313"},{"key":"1673_CR67","first-page":"9","volume":"14","author":"S Zheng-Hai","year":"2017","unstructured":"Zheng-Hai S, Jia-Jin Z, Jing-Wen M, Chuan Z, Yun-Feng H, Ping L, Ju-Guang S, Qin-Yi F (2017) Study about brain neurotransmitter changes in patients with Alzheimer\u2019s disease. Med Innov China 14:9\u201312","journal-title":"Med Innov China"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01673-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-025-01673-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01673-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T02:12:46Z","timestamp":1767492766000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-025-01673-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":67,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1673"],"URL":"https:\/\/doi.org\/10.1007\/s11011-025-01673-z","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"assertion":[{"value":"2 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments in this study were performed according to the Law on the Protection of Laboratory Animals (Directive 86\/609\/EEC) and were approved by the Laboratory Animal Ethics Committee of Heilongjiang University of Chinese Medicine (2021031201).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"290"}}